United States · Investor

Harbert Venture Partners

Filed with the SEC to raise a fund in Aug 2026, closing $15M. Last cheque observed Feb 2017.

QuietNew fund $15M, Aug 2026VC firm

Series BSeries CSeries A

Cheques on record
0%of best year0cheques in 12 months, 17 on record
Since the last cheque3553days00hrs00min00sec
Median round$33MRounds led0 of 17Sole investor2 roundsExits2 from the portfolioMostly inUnited States, 94%
Pitch Harbert Venture Partners

Harbert Venture Partners highlights

  1. 01

    17 rounds on record

  2. 02

    Mostly Series B and Series C: 69% of its rounds

  3. 03

    Sole investor in 2 rounds, median $42M

  4. 04

    2 exits from the portfolio

What they do

Filed 1 private fund offering with the SEC, the most recent in 2026-04From their own website
Type
VC firm (from a list, unverified)
Cheque size
Not stated
Based in
United States
Cold pitches
Not stated

The record

Every round we can evidence, newest first17 appearances

  1. 2017

    1 round

  2. Feb
    MapAnythingSeries B · US · FinSMEs$33MWith 5 others
  3. 2015

    5 rounds

  4. Oct
    Netsertive, IncSeries C · US$24MWith 4 others
  5. Oct
    CareSyncSeries B · US$18MWith 6 others
  6. Aug
    Iconixx SoftwareSeries B · US$10MWith 1 other
  7. Aug
    KineticorCA$80MSole investor
  8. Jan
    Clinipace WorldWideVenture · US$50MWith 6 others
  9. 2014

    4 rounds

  10. Sept
    WiserTogetherSeries B · US$9.0MWith 6 others
  11. Sept
    Netsertive, IncSeries B · US$3.0MWith 2 others
  12. Jul
    Healthcare InteractiveSeries A · US$8.0MWith 1 other
  13. Jul
    RacemiSeries C · US$10MWith 2 others
  14. 2013

    1 round

  15. Dec
    InvinceaSeries C · US$16MWith 4 others
  16. 2012

    1 round

  17. Oct
    IngagePatientSeries A · US$4.1MSole investor
  18. 2008

    1 round

  19. Aug
    ClarabridgeSeries C · US$12MWith 3 others
  20. 2007

    1 round

  21. Mar
    Agility Healthcare SolutionSeries A · US$5.3MWith 1 other
  22. 2006

    1 round

  23. Dec
    AldagenSeries C · US$14MWith 2 others
  24. 2004

    2 rounds

  25. Jul
    BroadSourceVenture · US$5.7MWith 1 other
  26. Mar
    MaxcyteSeries B · US$11MWith 2 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

Named by the firm itself, on a filing, its Form ADV or its company registration17 named

BCBrian C CarneyPartner in the General PartneriFiling they signed
CDCharles D MillerExecutive Officer of General PartneriFiling they signed
CHClaude H. EstesExecutive OfficeriFiling they signed
DWDavid W. BoutwellExecutive Officer of General PartneriFiling they signed
JTJ. Travis PritchettExecutive OfficeriFiling they signed
JWJohn W. McCulloughExecutive Officer of the Manager of the General Partner and PromoteriFiling they signed
MWMichael W. LuceExecutive Officer of trhe Manager of the General Partner and PromoteriFiling they signed
PEPatrick E MolonyPromoteriFiling they signed
RJRaymond J. HarbertChief Executive Officer and Chairman of the Board of the Managing MemberiFiling they signed
RJRaymond J. Harbert, Jr.Executive OfficeriFiling they signed
RLRobert L CrutchfieldPartner in the General PartneriFiling they signed
TDThomas D RobertsPartner in the General PartneriFiling they signed
TDThomas D Roberts IIIExecutive Officer of General PartneriFiling they signed
TNTodd N. JordanExecutive OfficeriFiling they signed
WBWayne B NelsonPromoteriFiling they signed
WLWayne L. HunterExecutive Officer of General PartneriFiling they signed
WWWilliam W. BrookeExecutive Officer of General PartneriFiling they signed

We also hold 15 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

Exits from the portfolio

Companies it backed that were later bought or listed2 in all

AldagenBought by Nuo TherapeuticsUndisclosedFeb 2012
BroadSourceBought by Movero, Inc.UndisclosedJul 2011

An exit counts when it came after the firm's first round in the company. From historical deal records.

Companies it bought

Acquisitions by the firm itself

Flight Display SystemsUndisclosedNov 2014

Who they invest alongside

The investors most often in the same rounds as Harbert Venture Partners. A count of rooms they were both in, not a relationship either has claimed.

GreycroftVC firm4rounds togetherGrotech VenturesVC firm4rounds togetherIntersouth PartnersVC firm3rounds togetherMerck Global Health Innovation FundCorporate VC2rounds togetherRRE VenturesVC firm2rounds togetherTall Oaks Ventures LLCGrowth equity2rounds together

Quick answers about Harbert Venture Partners

What does Harbert Venture Partners invest in?

Harbert Venture Partners invests most often at Series B and Series C (69% of the rounds on record).

How active is Harbert Venture Partners?

17 investments on record, 0 of them in the last 12 months. The most recent was in Feb 2017.

What has Harbert Venture Partners invested in recently?

Its most recent investments on record: MapAnything (Series B, Feb 2017).

How big are Harbert Venture Partners's cheques?

The median round it joins is $33M.

Does Harbert Venture Partners lead rounds?

Rarely, if at all: none of its 17 investments on record names it as the lead.

Where does Harbert Venture Partners invest?

Most of the companies it backs are in the United States (94%) and Canada (6%).

Is Harbert Venture Partners investing now?

No investments in the last 12 months; the latest was in Feb 2017.

Who does Harbert Venture Partners invest alongside?

Most often Greycroft (4 rounds together), Grotech Ventures (4 rounds together) and Intersouth Partners (3 rounds together).

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it